Showing 1,261 - 1,280 results of 1,614 for search '"Switzerland"', query time: 0.05s Refine Results
  1. 1261
  2. 1262
  3. 1263
  4. 1264
  5. 1265

    Coupled Dynamics of Vehicle-Bridge Interaction System Using High Efficiency Method by Lu Sun, Xingzhuang Zhao

    Published 2021-01-01
    “…For class A and B level pavement roughness, the dynamic load coefficient is simulated within 2.0, compatible with specifications of AASHTO standard, Australian standard, and Switzerland standard. However, the Chinese code underestimates the dynamic load coefficient for a bridge with a fundamental frequency of around 4 Hz. …”
    Get full text
    Article
  6. 1266

    ANAXAM @ TOMCAT 2.0: easy access to cutting-edge tomographic microscopy for industry by Margie P. Olbinado, Vladimir Novak, Christian Gruenzweig, Anne Bonnin, Federica Marone, Christian Matthias Schlepuetz, Goran Lovric, Marco Stampanoni

    Published 2025-02-01
    “…Five years ago, PSI (together with two Swiss institutes and the Canton of Aargau in Switzerland) has co-founded ANAXAM – a technology transfer center that facilitates the use of advanced analytical methods at large-scale facilities such as the SLS for industrial applications. …”
    Get full text
    Article
  7. 1267
  8. 1268
  9. 1269
  10. 1270
  11. 1271
  12. 1272

    Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model by Peter Wahlqvist, Jay Warner, Robert Morlock

    Published 2018-08-01
    “…This paper assesses at what price one such simple insulin infusion device, PAQ® (Cequr SA, Switzerland), may be cost-effective compared to MDI in people with T2D not in glycemic control in the United States. …”
    Get full text
    Article
  13. 1273
  14. 1274
  15. 1275
  16. 1276
  17. 1277

    Parental perception of treatment options for mucopolysaccharidosis: a survey to bridge the gap for personalized medicine by Anna-Maria Wiesinger, Florian B. Lagler

    Published 2025-01-01
    “…The questionnaire was distributed via patient organizations in Germany, Switzerland, and Austria. Results Most likely parents would choose an approach to repurposed treatments for their child (neuronopathic: 82%, 14/17 and non-neuronopathic: 94%, 16/17), followed by enzyme replacement therapy (ERT, both 88%, 15/17), hematopoietic stem cell therapy (HSCT, 70%, 12/17 and 76%, 13/17), and finally gene therapy (GT, 58%, 10/17 and 53%, 9/17). …”
    Get full text
    Article
  18. 1278
  19. 1279
  20. 1280